ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Diagnostic Tests"

  • Abstract Number: 2274 • 2013 ACR/ARHP Annual Meeting

    Assessment Of The Diagnostic Accuracy Of Different Strategies For Health Fair Case-Finding For Undiagnosed Inflammatory Arthritis

    Kaylynn Aiona1, Christopher C. Striebich2, M. Kristen Demoruelle3, Julia J. Rhiannon4, Stuart M. Weisman5, Marie L. Feser3, Lezlie A. Derber5, James H. Goddard6, Stacey Brake6, Jill Lysengen7, Laura Rosseisen7, John E. Hokanson1, Anna E. Baron1, Jill M. Norris8, V. Michael Holers9 and Kevin D. Deane3, 1Colorado School of Public Health, Aurora, CO, 2University of Colorado Denver, Aurora, CO, 3Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO, 4Rheumatology, University of Colorado School of Medicine, Aurora, CO, 5University of Colorado School of Medicine, Division of Rheumatology, Aurora, CO, 69Health Fair, Denver, CO, 7Arthritis Foundation, Great West Region, Denver Office, Denver, CO, 8Epidemiology, Colorado School of Public Health, Aurora, CO, 9Rheumatology Division, University of Colorado School of Medicine, Aurora, CO

    Background/Purpose:   Early treatment of inflammatory arthritis (IA), and especially rheumatoid arthritis (RA), leads to improved outcomes, although diagnostic delays may impede timely treatment. We…
  • Abstract Number: 1891 • 2013 ACR/ARHP Annual Meeting

    Proteomic Profile Of Tears: Can It Help To Diagnose Juvenile Arthritis – Associated Uveitis Prior To The Clinical Signs Of Joints Inflammation

    Vyacheslav Chasnyk1, Sergei Nekhai2, Alla Hynes3, Tatiana Ammosova4, Yuri Obukhov4, Ekaterina Gaidar5, Anatolyi Kononov5, Margarita Dubko6, Elena Serogodskaia6 and Tatiana Nikitina5, 1Hospital Pediatry, State Pediatric Medical University, Saint-Petersburg, Russia, 2Department of Medicine, Center for Sickle Cell Disease, Howard University, Washington, DC, 3Eye Care Physicians and Surgeons, Winchester, VA, 4Howard University, Washington, DC, 5Saint-Petersburg State Pediatric Medical University, St. Petersburg, Russia, 6State Pediatric Medical University, Saint-Petersburg, Russia

    Background/Purpose: Approximately 6% of all cases of uveitis arise in children (Nguyen, Foster, 1998). One of the common causes of uveitis is Juvenile Idiopathic Arthritis…
  • Abstract Number: 1578 • 2013 ACR/ARHP Annual Meeting

    Decreased Sensitivity Of a Commercial Anti-dsDNA Assay In Patients With Moderately To Severely Active Systemic Lupus Erythematosus

    Munther A. Khamashta1, Gabor G. Illei2, Stephen Yoo2, Liangwei Wang3 and Warren Greth2, 1Lupus Research Unit, The Rayne Institute, St Thomas Hospital, Kings College London School of Medicine, London, United Kingdom, 2Clinical Development, MedImmune, LLC, Gaithersburg, MD, 3Biostatistics, MedImmune, LLC, Gaithersburg, MD

    Background/Purpose: Anti-dsDNA autoantibodies are highly specific for SLE. Anti-dsDNA positivity is an important eligibility criterion in many SLE studies, and decreases in anti-dsDNA levels are…
  • Abstract Number: 1390 • 2013 ACR/ARHP Annual Meeting

    Chaperonin Protein 14-3-3n (eta) In Rheumatoid Arthritis and Arthritogenic Viral Infections

    Stanley J. Naides, Olga S Zhukov, Rania W Abolhosn and Joanna M Popov, Immunology, Quest Diagnostics Nichols Institute, San Juan Capistrano, CA

    Background/Purpose: The 14-3-3 proteins are ubiquitously-expressed intracellular chaperonins. Expression of the η (eta) isoform is restricted to synovial and CNS tissues. Extracellular 14-3-3η induces proinflammatory…
  • Abstract Number: 1325 • 2013 ACR/ARHP Annual Meeting

    A Novel Index To Identify Interstitial Lung Disease In Rheumatoid Arthritis Patients

    Jose Felix Restrepo1, Inmaculada Del Rincon2, Roy W. Haas3, Daniel F. Battafarano4 and Agustin Escalante5, 1Rheumatology, University of Texas Health Science Center at San Antonio, San Antonio, TX, 2Rheumatology, University of Texas Health Science Center, San Antonio, TX, 3Dept. of Medicine-Rheumatology, University of Texas Health Science Center, San Antonio, TX, 4Medicine / MCHE-MDR, San Antonio Military Medical Center, San Antonio, TX, 5Dept. of Medicine-Rheumatology, University of Texas Health Science Center at San Antonio, San Antonio, TX

    A Novel Index to Identify Interstitial Lung Disease in Rheumatoid Arthritis Patients José Félix Restrepo1, Inmaculada del Rincón1, Roy W Haas1, Daniel F Battafarano2, Agustín Escalante1…
  • Abstract Number: 1301 • 2013 ACR/ARHP Annual Meeting

    The Tumor Necrosis Factor Stimulated Gene-6 Promoter Reporter Can Monitor The Disease Activity In Rheumatoid Arthritis

    Mathijs G.A. Broeren1, Eline A. Vermeij1, Onno J. Arntz2, Miranda B. Bennink1, Emma Sterken1, Calin Popa2, Tim L. Jansen3, Wim B. van den Berg4 and Fons A.J. Van de Loo5, 1Rheumatology Research and Advanced Therapeutics, Department of Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 2Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 3Rheumatology, Radboud UMC, Nijmegen, Netherlands, 4Experimental Rheumatology (272), Radboud university medical center, Nijmegen, Netherlands, 5Rheumatology Research and Advanced Therapeutics, Rheumatology Research and Advanced Therapeutics, Department of Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands

    Background/Purpose: An important step in the optimal personalized treatment of rheumatoid arthritis (RA) patients, is the accurate assessment of disease activity, disease progression and therapy…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology